At a glance
ClinicalIndex Comparison RecordN/ACompleted· 129 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
In Brief
An observational study for Crohn's Disease and Ulcerative Colitis. Completed, enrolled 129 participants across 1 site.
Detailed Summary
An increase prevalence of CMV, EBV and or HHV-6 in diseased tissue of inflammatory bowel disease would suggest a role for these viruses in the etiology and/or exacerbation of IBD, whereas their absence would preclude such association.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn's Disease, Ulcerative Colitis
CountriesUnited States
CollaboratorsHoffmann-La Roche
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2005
First PostedSep 2005
Primary CompletionJun 2012
TodayJul 2026
First PostedSep 22, 2005
Enrollment StartApr 1, 2005
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 20.8 years ago